Lv4
610 积分 2024-12-11 加入
Synergizing Ferroptosis and Immunotherapy via a PROTAC/PDT/HPK1 Inhibitor‐Loaded Nanoplatform for Enhanced Antitumor Efficacy
1个月前
已完结
In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker
1个月前
已完结
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer
1个月前
已完结
BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)—Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd)
1个月前
已关闭
Abstract RF02-03: Trastuzumab deruxtecan (T-DXd) in combination with anastrozole or fulvestrant in patients with HER2-low HR+ advanced/metastatic breast cancer: a Phase 1b, open-label, multicenter, dose-expansion study (DESTINY-Breast08)
1个月前
已完结
DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC
1个月前
已完结
Prognostic Significance of Extracellular Matrix Degrading Enzymes—Cathepsin L and Matrix Metalloproteases-2 [MMP-2] in Human Pancreatic Cancer
4个月前
已完结
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
4个月前
已完结
Insertion of a Lysosomal Enzyme Cleavage Site into the Sequence of a Radiolabeled Neuropeptide Influences Cell Trafficking In Vitro and In Vivo
4个月前
已完结
Rethinking strategies in SCLC: Lessons learned from tiragolumab in the SKYSCRAPER-02 study
6个月前
已关闭
皖公网安备34019202002308
